The compounds anisomycin, cephaeline, digitoxin, mitoxantrone, digoxin, digitoxigenin, homoharringtonine, NCI724448, midostaurin, withaferin A and NCI718581 were found to be effective UBE2C targeting candidates which could result in significant growth inhibition at low doses across multiple cell lines.